AngioSafe
AngioSafe is seeking a hands‑on Individual Contributor to design, develop, prototype, test, and transfer interventional catheter devices to manufacturing. The role involves direct device building, troubleshooting, and cross‑functional collaboration within a fast‑paced startup environment.
AngioSafe is a medical device company advancing endovascular revascularization through its Santreva™-ATK Endovascular Revascularization Catheter and proprietary Atheroplasty™ technology. The Santreva™-ATK is a wire-free, all-in-one platform that uses intraplaque traversal, axial plaque cutting, lateral plaque compression, and channel formation to treat severely or totally occluded arteries, including chronic total occlusions (CTOs). The device is 510(k) cleared in the U.S. and CE marked in the EU, and is headquartered in San Jose, California.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AngioSafe.
AngioSafe didn’t post a salary, so this is our estimate from similar listings.